"People already know that our products and ingredients meet or exceed government regulatory standards. They want to know more," said Nettesheim. "This site provides moms, families and all consumers a way to hear directly from us about the art and science of ingredient selection and product formulation." She adds, "We want to share our policies and plans in a forum that is designed to help consumers better understand what we do to ensure that the products they choose are as safe as can be."
About the Johnson & Johnson Family of Consumer Companies The Johnson & Johnson Family of Consumer Companies includes, among other divisions, Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc., which markets the JOHNSON'S® baby, AVEENO®, RoC®, and CLEAN & CLEAR® brands, and Neutrogena Corporation, which markets the NEUTROGENA® brand.
Caring for the world, one person at a time…inspires and unites the people of the Johnson & Johnson Family of Consumer Companies. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. The Johnson & Johnson Family of Consumer Companies is part of the more than 250 operating companies of Johnson & Johnson (NYSE: JNJ), working with partners in health care to touch the lives of over a billion people every day, throughout the world.(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; significant adverse litigation or government action; impact of business combinations; financial distress and bankruptcies experienced by significant customers and suppliers; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; increased scrutiny of the health care industry by government agencies; changes in behavior and spending patterns of purchasers of health care products and services; financial instability of international economies and sovereign risk; disruptions due to natural disasters; manufacturing difficulties or delays; and product efficacy or safety concerns resulting in product recalls or regulatory action. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 1, 2012. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts